# Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence

> **NCT01509508** · NA · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 28153 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Immediate ARV treatment initiation with TDF/FTC/EFV
- **OTHER:** South African recommendation guided ARV (TDF/FTC/EFV) initiation

## Key facts

- **NCT ID:** NCT01509508
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 28153 (ACTUAL)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01509508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01509508, "Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01509508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*